T. Rowe Price Associates’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-5,527
Closed -$73K – 2595
2017
Q4
$73K Hold
5,527
– – ﹤0.01% 2533
2017
Q3
$81K Hold
5,527
– – ﹤0.01% 2518
2017
Q2
$579K Hold
5,527
– – ﹤0.01% 1999
2017
Q1
$708K Buy
+5,527
New +$583K ﹤0.01% 1928
2015
Q2
– Sell
-146,533
Closed -$16.2M – 2564
2015
Q1
$16.2M Buy
146,533
+75,416
+106% +$8.85M ﹤0.01% 1190
2014
Q4
$9.58M Sell
71,117
-1,050
-1% -$123K ﹤0.01% 1337
2014
Q3
$8.22M Buy
72,167
+27,584
+62% +$3.66M ﹤0.01% 1357
2014
Q2
$7.5M Buy
+44,583
New +$7.69M ﹤0.01% 1376

Other funds holding ARAV

T. Rowe Price Associates's ARAV Position: Q1 2018 in Review

T. Rowe Price Associates sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2018, closing a stake of 5,527 shares — an estimated $73K sold.

T. Rowe Price Associates first reported a position in ARAV in Q2 2014 and held it in 8 quarters. The position peaked at $16.2M in Q1 2015. 69 funds tracked by Wall St. Rank hold ARAV as of Q1 2018.

  • T. Rowe Price Associates reported no remaining Aravive, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 5,527 Aravive, Inc. Common Stock shares in Q1 2018, an estimated $73K.
  • T. Rowe Price Associates first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
  • T. Rowe Price Associates's Aravive, Inc. Common Stock position peaked at $16.2M in Q1 2015.
  • 69 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2018.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.